Coordinated Open Data Will Drive Next-Level Health Research

An Interview With European Data Cohesion Experts ELIXIR

Experts from a European data sharing initiative talk to In Vivo about the importance of coordinated computational biology efforts for the future of life sciences innovation and the effective use of artificial intelligence.

ELIXIR
Katharina Lauer at an ELIXIR innovation and SME event • Source: ELIXIR Europe

ELIXIR, founded in December 2013, is a joint effort between several European countries for the development of coordinated, integrated and sustainable public bioinformatics services. “There are many public databases, software tools and training courses that already have extensive usage by academia and the life sciences industry. However, there is lot of fragmentation, so those resources don’t always work closely together,” Andrew Smith, ELIXIR’s head of external relations, told In Vivo. The group aims to better coordinate the evolution of bioinformatic services across those member countries.

ELIXIR has connected 22 countries. In each participating country there is a national effort to coordinate the public bioinformatics services....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation

As Pricing Pressures Mount, Biopharma Turns To AI To Reduce Trial Failure Rates

 
• By 

With drug pricing policies potentially squeezing industry margins, companies are increasingly turning to AI-driven trial optimization to rescue sub-optimal studies and accelerate development timelines.

How Annexon Reclaimed Its Geographic Atrophy Program After Phase II Miss

The biotech's C1q inhibitor, vonaprument, preserved vision but missed the primary Phase II endpoint on lesion growth. The stakes are high for a Phase III with a different primary endpoint.

Rising Leaders 2025: Noam Solomon’s Quest To Create A ‘Google Maps’ Of the Immune System

 
• By 

The mathematician-turned-CEO is building an atlas of clinical immune biology to revolutionize precision medicine.

Three Approaches, One Goal: How Digital Twin Technologies Can Differ

 
• By 

Three digital twin approaches compete: image-based precision, phenotypic modeling and massive data aggregation.

More from In Vivo

How Annexon Reclaimed Its Geographic Atrophy Program After Phase II Miss

The biotech's C1q inhibitor, vonaprument, preserved vision but missed the primary Phase II endpoint on lesion growth. The stakes are high for a Phase III with a different primary endpoint.

Deals Shaping The Industry, August 2025

An interactive look at pharma, medtech and diagnostics deals made during August 2025. Data courtesy of Biomedtracker.

Rising Leaders 2025: Noam Solomon’s Quest To Create A ‘Google Maps’ Of the Immune System

 
• By 

The mathematician-turned-CEO is building an atlas of clinical immune biology to revolutionize precision medicine.